Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF-I/IGF-binding protein-3 ratio with indices of adiposity and plasma insulin concentrations (Sweden)

被引:0
|
作者
Annekatrin Lukanova
Stefan Söderberg
Pär Stattin
Richard Palmqvist
Eva Lundin
Carine Biessy
Sabina Rinaldi
Elio Riboli
Göran Hallmans
Rudolf Kaaks
机构
[1] International Agency for Research on Cancer,Department of Public Health and Clinical Medicine/Nutritional Research
[2] University of Umeå,Department of Nutrition and Cancer
[3] International Agency for Research on Cancer,University of Umeå, Department of Urology and Andrology and the Medical Biobank
[4] Northern Sweden University Hospital,Department of Pathology
[5] University of Umeå,Department of Medical Biosciences/Pathology, and Department of Public Health and Clinical Medicine/Nutritional Research
[6] University of Umeå,undefined
[7] International Agency for Research on Cancer,undefined
来源
Cancer Causes & Control | 2002年 / 13卷
关键词
body mass index; IGF-binding protein-3; IGF-I; insulin; leptin;
D O I
暂无
中图分类号
学科分类号
摘要
Objective: In this study we test the hypothesis of a nonlinear relationship of IGF-I with indices of body fat such as body mass index (BMI), insulin, and leptin. Methods: The controls used in three case–control cancer studies nested in the Northern Sweden Health and Disease Cohort, were combined for this analysis. Measurements of plasma IGF-I, IGFBP-3, insulin, and leptin were available for 445 men and 391 women. Results: In both men and women we found the highest mean IGF-I levels in subjects with BMI between 24 and 26. IGF-I concentrations decreased toward BMI ≤ 20 and BMI > 30 in men; however, the results for women did not reach statistical significance. The molar ratio of IGF-I/IGFBP-3 showed a similar profile to that of IGF-I, although much less pronounced. The observed peak mean IGF-I levels in the second quintiles of insulin and leptin in men supported these findings. No significant variation of mean IGF-I levels across quintiles of insulin and leptin were observed in women. Conclusions: The results of this study provide evidence that IGF-I plasma concentrations vary substantially over a wide range of body weight and that the relationship is nonlinear.
引用
收藏
页码:509 / 516
页数:7
相关论文
共 50 条
  • [11] Free insulin-like growth factor I (IGF-I) in healthy subjects: Relationship with IGF-binding proteins and insulin sensitivity
    Nyomba, BLG
    Berard, L
    Murphy, LJ
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (07): : 2177 - 2181
  • [12] Insulin-like growth factor (IGF)-I, IGF-binding protein-3 and colorectal adenomas in Japanese men
    Teramukai, S
    Rohan, T
    Lee, KY
    Eguchi, H
    Oda, T
    Kono, S
    JAPANESE JOURNAL OF CANCER RESEARCH, 2002, 93 (11): : 1187 - 1194
  • [13] Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians: Relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function
    Paolisso, G
    Ammendola, S
    DelBuono, A
    Gambardella, A
    Riondino, M
    Tagliamonte, MR
    Rizzo, MR
    Carella, C
    Varricchio, M
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (07): : 2204 - 2209
  • [14] Insulin like growth factor I (IGF-I), IGF-binding protein-3 and prostate cancer risk: epidemiological studies
    Chan, JM
    Stampfer, MJ
    Giovannucci, E
    Ma, J
    Pollak, M
    GROWTH HORMONE & IGF RESEARCH, 2000, 10 : S32 - S33
  • [15] Insulin, insulin-like growth factor I (IGF-I), IGF-binding protein-1, growth hormone, and feeding in the newborn
    Ogilvy-Stuart, AL
    Hands, SJ
    Adcock, CJ
    Holly, JMP
    Matthews, DR
    Mohamed-Ali, V
    Yudkin, JS
    Wilkinson, AR
    Dunger, DB
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (10): : 3550 - 3557
  • [16] Insulin-like growth factor I (IGF-I) and IGF-Binding proteins in rat wound fluid
    Robertson, JG
    Pickering, KJ
    Belford, DA
    ENDOCRINOLOGY, 1996, 137 (07) : 2774 - 2781
  • [17] Insulin-like growth factor I (IGF-I), IGF-binding protein-3 and the risk of colorectal adenoma and cancer in the Nurses' Health Study
    Giovannucci, E
    Pollak, M
    Platz, EA
    Willett, WC
    Stampfer, MJ
    Majeed, N
    Colditz, GA
    Speizer, FE
    Hankinson, SE
    GROWTH HORMONE & IGF RESEARCH, 2000, 10 : S30 - S31
  • [18] Effect of intraperitoneal insulin delivery on growth hormone binding protein, insulin-like growth factor (IGF)-I, and IGF-binding protein-3 in IDDM
    HanaireBroutin, H
    SallerinCaute, B
    Poncet, MF
    Tauber, M
    Bastide, R
    Chale, JJ
    Rosenfeld, R
    Tauber, JP
    DIABETOLOGIA, 1996, 39 (12) : 1498 - 1504
  • [19] ANALYSIS OF THE INTERACTION OF INSULIN-LIKE GROWTH-FACTOR-I (IGF-I) ANALOGS WITH THE IGF-I RECEPTOR AND IGF-BINDING PROTEINS
    CASCIERI, MA
    BAYNE, ML
    HORMONE RESEARCH, 1994, 41 : 80 - 86
  • [20] A prospective study of plasma levels of insulin-like growth factor I (IGF-I) and IGF-binding protein-3, and colorectal cancer risk among men
    Ma, J
    Pollak, M
    Giovannucci, E
    Chan, JM
    Tao, YZ
    Hennekens, C
    Stampfer, MJ
    GROWTH HORMONE & IGF RESEARCH, 2000, 10 : S28 - S29